Stock Screener App

Frei -

Installieren

3.38

0.60% 0.02

Neuphoria Therapeutics Inc (NEUP)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	452.97% 6.7001	1.2116	4.0608	5.6527	5.8218
Depreciation and Amortization	0.1657	-	0.1658	0.1658	0.1656
Operating Income/Loss	356.07% -5.5259	-1.2116	-4.0608	-5.6527	-5.835
Nonoperating Income/Loss	12.67% 0.5867	0.6718	5.8901	-4.2886	-3.3152
Income/Loss From Continuing Operations Before Tax	814.92% -4.9392	-0.5399	1.8293	-9.9413	-9.1503
Income Tax Expense/Benefit	0.00% -0.0348	-0.0348	-0.0348	-0.0348	-0.2666
Net Income/Loss	871.06% -4.9045	-0.5051	1.8641	-9.9065	-8.8837

SGMT

$8.775

1.74%

NVCT

$19.88

5.87%

WVE

$3.30

4.62%

OLMA

$7.46

4.60%

PRME

$3.605

9.65%

ZVRA

$11.26

1.14%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters